Data from Daley et al. showed that NLRP3 deletion delayed the malignant progression of pancreatic cancer, was protective against PDA, and NLRP3 signaling promoted accelerated progression of pancreatic tumors [55]. Here, NLRP3 is linked to familial pancreatic carcinoma.